ANALISIS KADAR UREUM, CREATININ, DAN ASAM URAT PADA OAT TB-PARU
Abstract
Tuberculosis (TB) is an infectious disease which is still a global health problem. At present, tuberculosis treatment is given in the form of a package in the form of fixed-dose combination anti-tuberculosis drugs in general, namely Rifampicin, Isoniazid, Ethambutol, and Pyranizamid. Anti-Tuberculosis is a long-term treatment. One of the side effects of using it can be nephrotoxic or destructive to cells in the kidney, which can decrease the kidney's excretory function with a marked increase in substances from blood chemistry, namely urea, creatinine, and uric acid. This study aimed to analyze urea, creatinine, and uric acid levels in patients with pulmonary tuberculosis consume Anti-Tuberculosis therapy at Dr. Lung Hospital. M. Goenawan Partowidigdo Cisarua Bogor. The research method was descriptive by taking secondary data from Gita Iftitah Renitia's research results. The descriptive tests analyzed DR-TB OAT side effects confirmed by laboratory results. The research result from the sample count, there were 243 patients, confirmed laboratory results found normal urea levels (20-40 mg/dL) in 97 people (59.5%); normal limit creatinine (0.5-1.5 mg/dL) 150 people (92%); uric acid was above normal (> 6 mg/dL) in 113 people (61.4%). The concluded that side effects of DR-TB OAT in the highest number of cases of uric acid levels above normal (> 6 mg/dL) were found in housewives.
Full text article
References
2. Risma. D-Iii Analis Kesehatan P, Kesehatan Masyarakat F, Indonesia Timur Jl Abdul Kadir No U. Pengaruh Lama Waktu Konsumsi Obat Pada Penderita Tb Terhadap Kadar Kreatinin Dan Ureum Dilaboratorium Rsuw Uit Makassar 2018. J Media Laboran . 2020;10(November):48-52.
3. Arisanti, Rini Eka. Gambaran Asam Urat Pada Penderita Tuberkulosis Paru Yang Mengkomsumsi Obat Anti Tuberkulosis (Oat) Di Puskesmas Mulyorejo Kecamatan Sunggal Medan. Program Studi Teknologi Laboratorium Medik. Published Online 2020 : 1-47.Poltekkes Kemenkes Medan
4. M. Fery Harison. Gambaran Kadar Ureum Dan Kreatinin Pada Penderita Tuberkulosis Paru Yang Mendapat Terapi Obat Anti Tuberkulosis (Oat) Di Rs. Khusus Paru Provinsi Sumatera Selatan. Program Studi Analis Kesehatan. Published Online 2019:1-82. Poltekkes Kemenkes Palembang
5. Nia Triputri Nanda. Analisa Kadar Ureum Dalam Serum Penderita Tb Paru Yang Mengkonsumsi Obat Anti Tuberkulosis. Program Studi D-Iii Analis Kesehatan Fakultas Ilmu Kesehatan Universitas Sari Mutiara Indonesia Medan 2015. Published Online 2015:1-55.
6. Aminah S. Perbedaan Kadar Sgot , Sgpt , Ureum , Dan Kreatinin Pada Penderita Tb Paru Setelah Enam Bulan Pengobatan Different Levels Sgot , Sgpt , Urea , And Creatinine Pulmonary Tb In Six Months After Treatment. J Anal Kesehat. 2013;2(2):260-269.
7. Kementerian Kesehatan Ri. Laporan Nasional: Riset Kesehatan Dasar (Riskesdas) 2018. Jakarta: Kementerian Kesehatan; 2018
8. Nafila N, Haqiqi Rn, Wahyunita S. Kadar Asam Urat Pada Pasien Tuberkulosis Dengan Terapi Obat Anti Tuberkulosis (Oat) Di Puskesmas Cempaka Maret 2017. J Ilm Manuntung. 2018;3(2):173-177. Doi:10.51352/Jim.V3i2.124
9. Dotulong, Jendra, Margareth R. Sapulete, And Grace D. Kandou. “Hubungan Faktor Risiko Umur, Jenis Kelamin Dan Kepadatan Hunian Dengan Kejadian Penyakit TB Paru Di Desa Wori Kecematan Wori.” Jurnal Kedokteran Komunitas Dan Tropik 2015 : 3(2):57–65.
10. Kondo, I., Dkk. Gambaran Kadar Asam Urat Pada Penderita Tuberkolosis Paru Yang Menerima Terapi Obat Anti Tuberkolosis Di RSUP Prof. Dr. R.D. Kandou. Jurnal E-Clinic (Eci), 2016; 4(1):344-348
11. Kementerian Kesehatan RI. Petunjuk Teknis Pemeriksaan TB Dengan TCM. 2017
12. Kementerian Kesehatan RI. Pedoman Nasional Penanggulangan Tuberkulosis. Direktorat Jenderal Pengendalian Penyakit Dan Penyehatan Lingkungan. 2014
13. Edmund, L. And David, J. Kidney Function Tests. In: Burtis, C., Ashwood, E. And Burns, D., Eds., Tietz Textbook Of Clinical Chemistry And Molecular Diagnostics, 24th Edition, Elsevier, New Delhi, 2010 : 797-808
14. Retno Asti Werdhani. Patofisiologi, Diagnosis, Dan Klasifikasi Tuberkulosis. 2002. Jakarta: Departemen Ilmu Kedokteran Komunitas, Okupasi, dan Keluarga. FKUI
15. Anggraeni DE, Rahayu SR. Gejala Klinis Tuberkulosis Pada Keluarga Penderita Tuberkulosis BTA Positif. Higeia J Public Heal Res Dev. 2018;2(1):91-101. Http://Journal.Unnes.Ac.Id/Sju/Index.Php/Higeia
16. World Health Organization. ART Adverse Drug Reaction Terminology. Geneva: WHO Collaborating For Drug International Monitoring. 1979
17. Manalu,LY, Gambaran Kadar Asam Urat Pada Penderita Tuberkulosis Paru Yang Menggkonsumsi Obat Anti Tuberkulosis (OAT) Di Rumah Sakit Khusus Paru Kota Medan. Published Online 2019;1-67. Poltekkes Kemenkes Medan
18. Saputra,AA. Gambaran Kadar Asam Urat Pada Pasien Tuberkulosis Paru Yang Mendapat Terapi Obat Anti Tuberkulosis (OAT) Di Rumah Sakit Khusus Paru Provinsi Sumatera Selatan Tahun 2018. Poltekkes Kemenkes Palembang 2018
19. Djasang S, Saturiski M. Studi Hasil Pemeriksaan Ureum Dan Asam Urat Pada Penderita Tuberkulosis Paru Yang Mengonsumsi Obat Anti Tuberkulosis (Oat) Fase Intensif. J Media Anal Kesehat. 2019;10(1):59. Doi:10.32382/Mak.V10i1.985
20. Wilson, Lorraine M, Patofisiologi Konsep Klinis Proses-Proses Penyakit Vol2, Edisi 6. EGC, Jakarta. 2006; 867-875.
21. Kementerian Kesehatan RI. Petunjuk Teknis: Penatalaksanaan Tuberkulosis Resisten Obat Di Indonesia. Jakarta: Kementerian Kesehatan RI. 2020
22. World Health Organization. WHO Operational Handbook On Tuberculosis, Module 4: Treatment, Drug-Resistant Tuberculosis Treatment. Geneva: WHO Press. 2020
23. Patricia NB, Kesehatan J, Poltekkes L, Surabaya K, Model HB, Tuberkulosis NP. Dari Laporan WHO Global Tuberculosis Menurut Teori Health Belief Model Edukasi Health Belief Model ( HBM ) Pada. 2020;18(1):58-64.
24. Kristini T, Hamidah R. Potensi Penularan Tuberculosis Paru Pada Anggota Keluarga Penderita. J Kesehat Masy Indones. 2020;15(1):24. Doi:10.26714/Jkmi.15.1.2020.24-28
25. Wahyuni, T., & Cahyati, W. H. Multidrug Resistant Tuberkulosis (MDR-TB). Higeia Journal Of Public Health Research And Development ,2020; 4(Special 3):636-648
26. Fortuna TA, Rachmawati H, Hasmono D, Karuniawati H. Studi Penggunaan Obat Anti Tuberkulosis (OAT) Tahap Lanjutan Pada Pasien Baru BTA Positif. Pharmacon J Farm Indones. 2022;19(1):62-71. Doi:10.23917/Pharmacon.V19i1.17907
27. Singh NP, Ganguli A, Prakash A. Drug Induced Kidney Disease. J Assoc Physicians India. 2003;51:970-979.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.